Clinical Trials Browser

Phase 2 × INDUSTRY × Biological Products × Clear all

NCT04436133 2022-05-06

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Phase 2 Completed

Papillomavirus Infections

NCT01413087 2019-11-01

LAPC-BC-819

Phase 2 Terminated

12 enrolled 19 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms